Cell & Gene Therapy Europe | Berlin 2017
Phacilitate’s 3rd Cell & Gene Therapy Europe, the only European event offering extensive coverage of ATMP R&D, manufacturing & regulatory issues & challenges translating innovation to global success
Meet the future of ATMP commercialisation at Europe’s premier partnering event at Phacilitate’s 3rd Cell & Gene Therapy Europe. Join 400 industry decision-makers and key external stakeholders at the event which defines the strategic roadmap to European success for cell & gene therapy developers, ensuring European patients gain access to the game-changing biotherapeutics of tomorrow.
Be a part of the only European event that offers extensive coverage of ATMP R&D, manufacturing and regulatory issues and challenges, translating innovation to global success.
For sponsorship enquiries visit: http://www.cgteurope.com/forms/sponsorship-enquiry
On Wednesday September 20, 2017 at 9:00 am (ends Thursday September 21, 2017 at 5:30 pm)
Category: Conferences - Science, Health & Medicine - Stem Cells
Early Bird - Pharma/Biotech: GBP 1550
Early Bird - Academic/Govt/Not-for-Profit: GBP 895
Early Bird - Technology/Science Provider: GBP 2400
Venue: Martim proArte Hotel, Friedrichstraße 151, Berlin, 10117